Efficacy and safety of sustained-release alfuzosin 5 mg in patients with benign prostatic hyperplasia

European Urology

Volumn 31, Issue 2, 1997, Pages 190-198

  Buzelin, J M ^a   Roth, S ^a   Geffriaud Ricouard, C ^a   Delauche Cavallier, M C ^a   Coulange, C ^a   Delmas, V ^a   Jacqumin, D ^a   Jung, J L ^a   Hode, E ^a   Tenaillon, M ^a   Toubol, J ^a   Delaere, P J ^a   Corbusier, A ^a   Djurhuns, J C ^a   Nerstrom, B ^a   Herzig, J ^a   Henke, G ^a   Grothuesman, H ^a   Wege, B ^a   Kutscher, K R ^a   Kochs, K ^a   Tietze, M ^a   Albrecht, J ^a   Schonherr, G ^a   Quast, D ^a   Vardakis, G ^a   Preiss, H ^a   Bassiri, A M ^a   Kuhn, E ^a   Pilaski, K ^a   Winkler, W P ^a   Knupfer, E ^a   Wulsch, E ^a   Matz, H J ^a   Wulff, H J ^a   Wittkowsky, K ^a   Schutt, W ^a   Simon, J ^a   Bohm, G ^a   Coors, H ^a   Widjaja, F ^a   Siegmund, H ^a   Schmidt, J M ^a   Krause, U ^a   Engels, K G ^a   Brickenkamp, A ^a   Heising, J ^a   Schaefer, R M ^a   Nelles, P ^a   Proffit, O ^a   Cozette, V ^a   Pellegri Geugnault, B ^a   more..

^a HÔTEL DIEU   (France)

Author keywords

Benign prostatic hyperplasia; Sustained release alfuzosin; 1 blockers

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; RESIDUAL URINE; SUSTAINED RELEASE PREPARATION; SYNCOPE; URINE FLOW RATE; VERTIGO;

EID: 8044231943     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000474449     Document Type: Article

References (21)